http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. Despite modern advances, the half-century-old method of producing flu vaccine still takes six months and requires hundreds of millions of fertilized chicken eggs. http://medicalxpress.com/news/2013-02-ideal-flu-vaccine-closer-reality.html Medications Fri, 15 Feb 2013 12:30:01 EST news280150036 (HealthDay)—The U.S. Food and Drug Administration has approved a novel type of flu vaccine, the agency announced Wednesday. http://medicalxpress.com/news/2013-01-fda-flu-vaccine.html Medications Thu, 17 Jan 2013 05:00:01 EST news277619466 After the SARS-CoV (severe acute respiratory syndrome coronavirus) outbreak in 2003, academia experts in immunology and molecular biology joined forces with industrial vaccine production experts in order to develop preventive and therapeutic measures for SARS. http://medicalxpress.com/news/2012-08-sars.html Diseases, Conditions, Syndromes Tue, 28 Aug 2012 09:20:58 EST news265364451 (Medical Xpress) -- When a new strain of influenza began to sicken even healthy younger adults three years ago, public interest in getting the newly developed H1N1 vaccine started strong but declined over time even as more people were getting sick, a new study shows. http://medicalxpress.com/news/2012-02-pandemic-flu-vaccine.html Health Fri, 17 Feb 2012 06:00:02 EST news248679722 New research from the laboratory of Dr. Elizabeth Leadbetter at the Trudeau Institute may lead to a whole new class of vaccines. Dr. Leadbetter's lab has discovered new properties of a potential vaccine adjuvant that suggest it could be useful for enhancing protection against a number of different infections. This new data will be published in the January 2012 issue of the journal Nature Immunology (Vol. 13, pp. 44-50). The paper, "iNKT cells direct B cell responses to cognate lipid antigen in an interleukin 21-dependent manner," is now available through Advance Online Publication (AOP) on Nature Immunology's website. http://medicalxpress.com/news/2011-12-advantages-vaccine-adjuvant.html Medical research Mon, 12 Dec 2011 12:00:04 EST news242912269 A new treatment using leukemia patients' own infection-fighting cells appears to protect them from infections and cancer recurrence following treatment with fludarabine-based chemotherapy, according to new research from the Perelman School of Medicine at the University of Pennsylvania. The new process is a step toward eliminating the harsh side effects that result from the commonly prescribed drug, which improves progression-free survival in patients with chronic lymphocytic leukemia (CLL) but destroys patients' healthy immune cells in the process, leaving them vulnerable to serious viral and bacterial infections. The drug's effects on the immune system tend to be so violent that it has been dubbed "AIDS in a bottle." http://medicalxpress.com/news/2011-12-immune-leukemia-patients-chemotherapy.html Cancer Mon, 12 Dec 2011 03:59:37 EST news242884769